1975
DOI: 10.1007/978-1-349-04233-3
|View full text |Cite
|
Sign up to set email alerts
|

Interpreting Cardiac Arrhythmias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2003
2003
2010
2010

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Quinoxaline 1,4-di-N-oxide derivatives even improve the biological results shown by their reduced analogues and are endowed with antiviral, anticancer, antibacterial and antiprotozoal activities. [5][6][7][8][9] There are many publications regarding 1,4-di-N-oxide derivatives, and more specifically alkyl and arylcarboxamide derivatives, in which their antibacterial and antimicrobial activities [10][11][12][13][14] have been reported or their capability to act as antitumoral agents [15,16] has been clearly demonstrated, thereby reflecting the growing interest in these structures over the past forty years.…”
Section: Tuberculosis (Mtbc) the Report Published By Who In 2009 Esmentioning
confidence: 99%
See 1 more Smart Citation
“…Quinoxaline 1,4-di-N-oxide derivatives even improve the biological results shown by their reduced analogues and are endowed with antiviral, anticancer, antibacterial and antiprotozoal activities. [5][6][7][8][9] There are many publications regarding 1,4-di-N-oxide derivatives, and more specifically alkyl and arylcarboxamide derivatives, in which their antibacterial and antimicrobial activities [10][11][12][13][14] have been reported or their capability to act as antitumoral agents [15,16] has been clearly demonstrated, thereby reflecting the growing interest in these structures over the past forty years.…”
Section: Tuberculosis (Mtbc) the Report Published By Who In 2009 Esmentioning
confidence: 99%
“…Moreover, ketone, carboxylate and carboxamide quinoxaline-1,4-dioxydes derivatives were actually patented in the 70's for their antibacterial activity. [12][13][14][15] These studies have facilitated a wide structure-activity relationship (SAR) analysis which lead us to design a group of thirty-six 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives that were prepared and tested against M.Tbc and to justify the design of the compounds presented in this paper. [22] Continuing with the antituberculosis project and in an attempt to establish the structural requirements necessary for the development of anti-tuberculosis drugs, nine series of quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives were proposed ( Figure 2).…”
Section: Tuberculosis (Mtbc) the Report Published By Who In 2009 Esmentioning
confidence: 99%
“…anticancer, antibacterial and antiprotozoal activities. [5][6][7][8][9] There are many publications regarding 1,4-di-N-oxide derivatives, and more specifically alkyl and arylcarboxamide derivatives, in which their antibacterial and antimicrobial activities [10][11][12][13][14] have been reported or their capability to act as antitumoral agents [15,16] has been clearly demonstrated, thereby reflecting the growing interest in these structures over the past forty years.…”
Section: Tuberculosis (Mtbc) the Report Published By Who In 2009 Esmentioning
confidence: 99%